Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma

Despite the advances in screening protocols and treatment options, hepatocellular carcinoma (HCC) is still considered to be the most lethal malignancy in patients with liver cirrhosis. Moreover, the survival outcomes after failure of first-line therapy for unresectable HCC is still poor with limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd El Aziz, Mohamed A., Facciorusso, Antonio, Nayfeh, Tarek, Saadi, Samer, Elnaggar, Mohamed, Cotsoglou, Christian, Sacco, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712941/
https://www.ncbi.nlm.nih.gov/pubmed/33086471
http://dx.doi.org/10.3390/vaccines8040616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712941/
https://www.ncbi.nlm.nih.gov/pubmed/33086471
http://dx.doi.org/10.3390/vaccines8040616

Ejemplares similares